US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Liminatus Pharma LLC

4.61

-0.0600-1.28%

Pre-market: 4.51-0.0997-2.16%04:22 EDT

Volume:73.21K

Turnover:335.21K

Market Cap:6.19M

PE:-0.26

High:4.84

Open:4.64

Low:4.35

Close:4.67

52wk High:171.00

52wk Low:4.35

Shares:1.34M

Float Shares:581.43K

Volume Ratio:0.83

T/O Rate:12.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-18.0650

EPS(LYR):-21.4999

ROE:--

ROA:-95.65%

PB:20.60

PE(LYR):-0.21

Loading ...

Overview Company News Filings

Liminatus Pharma Amends Innocsai Merger Terms, Targets July 2 Close

Liminatus Pharma - Innocsai Equity Holders to Receive up to 19.99% of Liminatus Common Stock

THOMSON REUTERS

Liminatus Pharma Amends Definitive Merger Agreement with Innocsai to Expand Oncology Cell Therapy Pipeline

THOMSON REUTERS

Liminatus Pharma - Innocsai Merger Valued at $320 Mln with $0.2 Per Share Issue Price

THOMSON REUTERS

Liminatus Pharma Announces Annual Shareholder Meeting

Liminatus Pharma issues new warrants for 20,688,000 shares in inducement deal

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

THOMSON REUTERS

Liminatus Pharma appeals Nasdaq delisting notice after missing $50 million market value rule

Liminatus Pharma receives Nasdaq delisting notice

Liminatus Pharma appeals Nasdaq delisting notice, trading suspension set May 29

Liminatus Pharma Announces Nasdaq Delisting Notification

THOMSON REUTERS

NASD Most Active Issues

Liminatus Pharma agrees to merge with InnocsAI in $320 million stock deal

Liminatus Pharma Inc - Innocsai Members to Receive 20% of Future Net Proceeds From Certain Strategic Deals

THOMSON REUTERS

Liminatus Pharma Announces Proposed Merger With Innocsai to Expand Oncology Cell Therapy Pipeline

THOMSON REUTERS

Top Premarket Gainers

MT Newswires Live

Liminatus Pharma Inc - Enters Merger Agreement With Innocsai Llc on May 17, 2026 - SEC Filing

THOMSON REUTERS

Liminatus Pharma Inc - Innocsai Members to Receive 1.6 Bln Shares at $0.20 per Share and 20% Contingent Value Rights - SEC Filing

THOMSON REUTERS

Liminatus Pharma agrees to buy InnocsAI in 1,600,000,000-share deal at $0.2 each

Liminatus Pharma Q1 FY26 net loss widens to $1.12 million; operating loss widens 317% to $1.1 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/LIMN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LIMN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LIMN\",,,,,undefined,":{"symbol":"LIMN","market":"US","secType":"STK","nameCN":"Liminatus Pharma LLC","latestPrice":4.61,"timestamp":1787688000000,"preClose":4.67,"halted":0,"volume":73212,"hourTrading":{"tag":"盘前","latestPrice":4.5103,"preClose":4.61,"latestTime":"04:22 EDT","volume":22,"amount":99.86390700000001,"timestamp":1787732561065,"change":-0.0997,"changeRate":-0.021627,"amplitude":0.030369},"delay":0,"changeRate":-0.012847965738757947,"floatShares":581432,"shares":1343208,"eps":-18.06505,"marketStatus":"Pre-Mkt","change":-0.06,"latestTime":"08-26 05:19:18 EDT","open":4.64,"high":4.8399,"low":4.35,"amount":335213.734464,"amplitude":0.104904,"askPrice":5.36,"askSize":100,"bidPrice":4.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-18.06505,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":4.61,"preHourTrading":{"tag":"盘前","latestPrice":4.5103,"preClose":4.61,"latestTime":"04:22 EDT","volume":22,"amount":99.86390700000001,"timestamp":1787732561065,"change":-0.0997,"changeRate":-0.021627,"amplitude":0.030369},"postHourTrading":{"tag":"盘后","latestPrice":4.59,"preClose":4.61,"latestTime":"19:57 EDT","volume":4621,"amount":21027.3581,"timestamp":1787702228764,"change":-0.02,"changeRate":-0.004338,"amplitude":0.025662},"volumeRatio":0.8259942452266094},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LIMN\",,,,,undefined,":{"symbol":"LIMN","floatShares":581432,"roa":"-95.65%","roe":"--","lyrEps":-21.49995,"volumeRatio":0.8259942452266094,"shares":1343208,"dividePrice":0,"high":4.8399,"amplitude":0.104904,"preClose":4.67,"low":4.35,"week52Low":4.35,"pbRate":"20.60","week52High":171,"institutionHeld":0,"latestPrice":4.61,"eps":-18.06505,"divideRate":0,"volume":73212,"delay":0,"ttmEps":-18.06505,"open":4.64,"prevYearClose":30.5,"prevWeekClose":5.16,"prevMonthClose":5.15,"prevQuarterClose":5.52,"fiveDayClose":6.5,"twentyDayClose":5.22,"sixtyDayClose":8.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LIMN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-21","symbol":"LIMN","defaultRemindTime":1787319000000,"type":"split","dateTimestamp":1787284800000,"forFactor":50,"toFactor":1,"ratio":50},{"market":"US","date":"2026-08-14","symbol":"LIMN","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2026-05-15","symbol":"LIMN","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2026-03-31","symbol":"LIMN","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"post","actualEps":-0.03},{"date":"2025-11-14","symbol":"LIMN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763110800000,"name":null,"time":"Pre-MKt","dateTimestamp":1763096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LIMN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LIMN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LIMN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LIMN","date":"2026-08-25","current":-0.255189,"percent":0.939394,"low":-195.659531,"twenty":-28.645055,"median":-16.763724,"eighty":-3.979343,"high":-0.403391,"avg":-21.431332,"sd":25.459588,"marketCap":6272776},"quantilePoints":[{"date":"2024-05-31","current":-29.356886,"twenty":-27.648492,"median":-26.153647,"eighty":-25.797732,"marketCap":85956962},{"date":"2024-06-07","current":-28.227775,"twenty":-27.609218,"median":-27.049572,"eighty":-26.224831,"marketCap":82650925},{"date":"2024-06-14","current":-27.12321,"twenty":-28.473234,"median":-27.160029,"eighty":-26.818841,"marketCap":79416758},{"date":"2024-06-21","current":-28.424142,"twenty":-28.841422,"median":-27.258212,"eighty":-27.034844,"marketCap":83225888},{"date":"2024-06-28","current":-28.645055,"twenty":-28.762875,"median":-28.227775,"eighty":-27.05939,"marketCap":83872721},{"date":"2024-07-05","current":-28.0805,"twenty":-28.645055,"median":-28.227775,"eighty":-27.083936,"marketCap":82219703},{"date":"2024-07-12","current":-27.442306,"twenty":-28.645055,"median":-28.092773,"eighty":-27.12321,"marketCap":80351073},{"date":"2024-07-19","current":-28.49778,"twenty":-28.645055,"median":-28.227775,"eighty":-27.137937,"marketCap":83441499},{"date":"2024-07-26","current":-27.098664,"twenty":-28.645055,"median":-28.092773,"eighty":-27.103573,"marketCap":79344888},{"date":"2024-08-02","current":-27.074118,"twenty":-28.6156,"median":-28.0805,"eighty":-27.074118,"marketCap":79273018},{"date":"2024-08-09","current":-16.785464,"twenty":-28.49778,"median":-27.761403,"eighty":-27.074118,"marketCap":79344888},{"date":"2024-08-16","current":-16.869239,"twenty":-28.49778,"median":-27.368669,"eighty":-27.074118,"marketCap":79740894},{"date":"2024-08-23","current":-15.964436,"twenty":-28.49778,"median":-27.160029,"eighty":-25.940098,"marketCap":75463888},{"date":"2024-08-30","current":-16.359746,"twenty":-28.49778,"median":-27.098664,"eighty":-16.869239,"marketCap":77332518},{"date":"2024-09-06","current":-16.800668,"twenty":-28.49778,"median":-27.098664,"eighty":-16.800668,"marketCap":79416758},{"date":"2024-09-13","current":-15.872679,"twenty":-28.424142,"median":-27.074118,"eighty":-16.724647,"marketCap":75030154},{"date":"2024-09-20","current":-16.325753,"twenty":-28.424142,"median":-27.074118,"eighty":-16.597597,"marketCap":77171833},{"date":"2024-09-27","current":-16.189831,"twenty":-28.227775,"median":-27.074118,"eighty":-16.526992,"marketCap":76529329},{"date":"2024-10-04","current":-16.688212,"twenty":-28.227775,"median":-27.074118,"eighty":-16.344693,"marketCap":78885176},{"date":"2024-10-11","current":-16.688212,"twenty":-28.227775,"median":-26.767294,"eighty":-16.359746,"marketCap":78885176},{"date":"2024-10-18","current":-16.824134,"twenty":-28.105045,"median":-25.797732,"eighty":-16.496584,"marketCap":79527680},{"date":"2024-10-25","current":-16.899646,"twenty":-28.0805,"median":-16.899646,"eighty":-16.526992,"marketCap":79884626},{"date":"2024-11-01","current":-16.899646,"twenty":-28.0805,"median":-16.899646,"eighty":-16.587809,"marketCap":79884626},{"date":"2024-11-08","current":-16.763724,"twenty":-28.0805,"median":-16.899646,"eighty":-16.587809,"marketCap":79242123},{"date":"2024-11-15","current":-16.522085,"twenty":-28.0805,"median":-16.869239,"eighty":-16.522085,"marketCap":78099894},{"date":"2024-11-22","current":-16.572225,"twenty":-28.0805,"median":-16.837108,"eighty":-16.522085,"marketCap":78336906},{"date":"2024-11-29","current":-16.572225,"twenty":-27.569945,"median":-16.824134,"eighty":-16.522085,"marketCap":78336906},{"date":"2024-12-06","current":-16.748621,"twenty":-27.442306,"median":-16.824134,"eighty":-16.522085,"marketCap":79170733},{"date":"2024-12-13","current":-17.05067,"twenty":-27.383396,"median":-16.824134,"eighty":-16.526011,"marketCap":80598519},{"date":"2024-12-20","current":-17.201695,"twenty":-27.329395,"median":-16.850082,"eighty":-16.563178,"marketCap":81312412},{"date":"2024-12-27","current":-17.201695,"twenty":-27.245939,"median":-16.869239,"eighty":-16.572225,"marketCap":81312412},{"date":"2025-01-03","current":-16.944953,"twenty":-27.167392,"median":-16.899646,"eighty":-16.572225,"marketCap":80098794},{"date":"2025-01-10","current":-16.944953,"twenty":-27.12321,"median":-16.899646,"eighty":-16.572225,"marketCap":80098794},{"date":"2025-01-17","current":-17.503744,"twenty":-27.118301,"median":-16.899646,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-01-24","current":-17.503744,"twenty":-27.098664,"median":-16.9223,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-01-31","current":-17.503744,"twenty":-27.098664,"median":-16.944953,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-02-07","current":-20.239774,"twenty":-27.098664,"median":-16.944953,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-02-14","current":-20.239774,"twenty":-27.074118,"median":-16.944953,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-02-21","current":-20.239774,"twenty":-27.074118,"median":-16.975158,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-02-28","current":-20.414406,"twenty":-27.074118,"median":-17.05067,"eighty":-16.572225,"marketCap":83454091},{"date":"2025-03-07","current":-26.194704,"twenty":-27.074118,"median":-17.05067,"eighty":-16.584692,"marketCap":107083950},{"date":"2025-03-14","current":-26.194704,"twenty":-27.074118,"median":-17.201695,"eighty":-16.587809,"marketCap":107083950},{"date":"2025-03-21","current":-26.194704,"twenty":-27.074118,"median":-17.201695,"eighty":-16.595639,"marketCap":107083950},{"date":"2025-03-28","current":-15.716822,"twenty":-27.074118,"median":-17.201695,"eighty":-16.587809,"marketCap":64250370},{"date":"2025-04-04","current":-15.716822,"twenty":-27.074118,"median":-17.201695,"eighty":-16.572225,"marketCap":64250370},{"date":"2025-04-11","current":-15.716822,"twenty":-27.074118,"median":-17.05067,"eighty":-16.572225,"marketCap":64250370},{"date":"2025-04-17","current":-12.11383,"twenty":-27.074118,"median":-17.05067,"eighty":-16.554132,"marketCap":49521339},{"date":"2025-04-25","current":-9.258427,"twenty":-27.05939,"median":-16.998323,"eighty":-16.522085,"marketCap":37848451},{"date":"2025-05-02","current":-51.163808,"twenty":-27.074118,"median":-17.05067,"eighty":-16.522085,"marketCap":209157649},{"date":"2025-05-09","current":-54.655673,"twenty":-27.074118,"median":-17.05067,"eighty":-16.522085,"marketCap":193809015},{"date":"2025-05-16","current":-47.319341,"twenty":-27.098664,"median":-17.201695,"eighty":-16.522085,"marketCap":167794382},{"date":"2025-05-23","current":-40.349825,"twenty":-27.152665,"median":-17.201695,"eighty":-16.525029,"marketCap":143080481},{"date":"2025-05-30","current":-38.295653,"twenty":-27.412851,"median":-17.201695,"eighty":-16.545085,"marketCap":135796384},{"date":"2025-06-06","current":-180.473765,"twenty":-28.0805,"median":-17.201695,"eighty":-16.572225,"marketCap":639959971},{"date":"2025-06-13","current":-149.000565,"twenty":-28.178683,"median":-17.503744,"eighty":-16.572225,"marketCap":528357196},{"date":"2025-06-20","current":-93.904837,"twenty":-28.384869,"median":-17.503744,"eighty":-16.572225,"marketCap":332987302},{"date":"2025-06-27","current":-121.782835,"twenty":-28.49778,"median":-17.503744,"eighty":-16.572225,"marketCap":431842907},{"date":"2025-07-03","current":-66.173564,"twenty":-28.645055,"median":-17.503744,"eighty":-16.572225,"marketCap":234651989},{"date":"2025-07-11","current":-52.821471,"twenty":-28.645055,"median":-17.503744,"eighty":-16.572225,"marketCap":187305357},{"date":"2025-07-18","current":-40.129645,"twenty":-29.356886,"median":-17.503744,"eighty":-16.572225,"marketCap":142300042},{"date":"2025-07-25","current":-62.138591,"twenty":-38.295566,"median":-17.503744,"eighty":-16.572225,"marketCap":220343941},{"date":"2025-08-01","current":-45.998697,"twenty":-39.616103,"median":-17.637767,"eighty":-16.572225,"marketCap":163111748},{"date":"2025-08-08","current":-35.434403,"twenty":-39.616103,"median":-19.593638,"eighty":-16.572225,"marketCap":125650677},{"date":"2025-08-15","current":-30.225619,"twenty":-39.542829,"median":-20.239774,"eighty":-16.587809,"marketCap":107180287},{"date":"2025-08-22","current":-20.394957,"twenty":-38.882559,"median":-20.239774,"eighty":-16.587809,"marketCap":72320679},{"date":"2025-08-29","current":-20.24823,"twenty":-38.295653,"median":-20.239774,"eighty":-16.597597,"marketCap":71800387},{"date":"2025-09-05","current":-20.761772,"twenty":-38.295583,"median":-20.239774,"eighty":-16.597597,"marketCap":73621411},{"date":"2025-09-12","current":-15.259536,"twenty":-37.532589,"median":-20.239774,"eighty":-16.595639,"marketCap":54110436},{"date":"2025-09-19","current":-9.463847,"twenty":-37.224531,"median":-20.239774,"eighty":-16.572225,"marketCap":33558876},{"date":"2025-09-26","current":-10.637657,"twenty":-36.432159,"median":-20.239774,"eighty":-16.572225,"marketCap":37721217},{"date":"2025-10-03","current":-14.379178,"twenty":-35.595802,"median":-19.5908,"eighty":-16.563178,"marketCap":50988680},{"date":"2025-10-10","current":-39.623683,"twenty":-38.295583,"median":-20.239774,"eighty":-16.572225,"marketCap":41408888},{"date":"2025-10-17","current":-31.854333,"twenty":-37.532589,"median":-20.239774,"eighty":-16.572225,"marketCap":33289498},{"date":"2025-10-24","current":-31.077398,"twenty":-37.224531,"median":-20.239774,"eighty":-16.572225,"marketCap":32477559},{"date":"2025-10-31","current":-36.515943,"twenty":-36.858977,"median":-20.239774,"eighty":-16.572225,"marketCap":38161132},{"date":"2025-11-07","current":-33.149225,"twenty":-36.774921,"median":-20.24823,"eighty":-16.572225,"marketCap":34642730},{"date":"2025-11-14","current":-27.71068,"twenty":-36.567739,"median":-20.414406,"eighty":-16.572225,"marketCap":28959157},{"date":"2025-11-21","current":-12.535267,"twenty":-36.515943,"median":-20.414406,"eighty":-16.572225,"marketCap":28417864},{"date":"2025-11-28","current":-12.415884,"twenty":-36.515943,"median":-20.24823,"eighty":-16.572225,"marketCap":28147218},{"date":"2025-12-05","current":-11.377247,"twenty":-36.351216,"median":-20.239774,"eighty":-16.522085,"marketCap":25792595},{"date":"2025-12-12","current":-10.290857,"twenty":-36.095351,"median":-20.239774,"eighty":-16.522085,"marketCap":23329713},{"date":"2025-12-19","current":-9.668869,"twenty":-35.659836,"median":-20.239774,"eighty":-16.344693,"marketCap":21919646},{"date":"2025-12-26","current":-8.452352,"twenty":-35.245471,"median":-20.239774,"eighty":-16.2442,"marketCap":19161760},{"date":"2026-01-02","current":-7.282393,"twenty":-34.865795,"median":-19.737527,"eighty":-16.189831,"marketCap":16509426},{"date":"2026-01-09","current":-9.79064,"twenty":-34.421573,"median":-17.973972,"eighty":-16.189831,"marketCap":22195705},{"date":"2026-01-16","current":-9.299974,"twenty":-34.133342,"median":-17.637767,"eighty":-15.89103,"marketCap":21083349},{"date":"2026-01-23","current":-9.192529,"twenty":-33.92616,"median":-17.570756,"eighty":-15.872679,"marketCap":20839767},{"date":"2026-01-30","current":-7.047208,"twenty":-33.453673,"median":-17.503744,"eighty":-15.716822,"marketCap":15976252},{"date":"2026-02-06","current":-24.473617,"twenty":-33.149225,"median":-17.503744,"eighty":-15.716822,"marketCap":55482497},{"date":"2026-02-13","current":-5.791293,"twenty":-33.149225,"median":-17.503744,"eighty":-15.716822,"marketCap":13129053},{"date":"2026-02-20","current":-3.714213,"twenty":-32.942042,"median":-17.503744,"eighty":-15.716822,"marketCap":8420243},{"date":"2026-02-27","current":-3.583288,"twenty":-32.871404,"median":-17.503744,"eighty":-14.841366,"marketCap":8123432},{"date":"2026-03-06","current":-5.166692,"twenty":-32.51455,"median":-17.503744,"eighty":-13.347074,"marketCap":11713062},{"date":"2026-03-13","current":-4.71139,"twenty":-32.309133,"median":-17.503744,"eighty":-12.660514,"marketCap":10680876},{"date":"2026-03-20","current":-3.973008,"twenty":-32.146606,"median":-17.201695,"eighty":-12.310337,"marketCap":9006940},{"date":"2026-03-27","current":-3.862152,"twenty":-31.95304,"median":-17.201695,"eighty":-12.11383,"marketCap":8755626},{"date":"2026-04-02","current":-3.385074,"twenty":-31.877789,"median":-17.201695,"eighty":-11.685646,"marketCap":7674075},{"date":"2026-04-10","current":-0.905773,"twenty":-31.543559,"median":-17.201695,"eighty":-11.088339,"marketCap":9244792},{"date":"2026-04-17","current":-1.0113,"twenty":-31.336376,"median":-17.061255,"eighty":-10.609247,"marketCap":10321855},{"date":"2026-04-24","current":-0.878073,"twenty":-31.180989,"median":-17.05067,"eighty":-10.468972,"marketCap":8962063},{"date":"2026-05-01","current":-0.897419,"twenty":-30.922011,"median":-17.024496,"eighty":-10.104619,"marketCap":9159524},{"date":"2026-05-08","current":-0.88159,"twenty":-30.81842,"median":-16.946888,"eighty":-9.58686,"marketCap":8997965},{"date":"2026-05-15","current":-0.80904,"twenty":-30.507646,"median":-16.944953,"eighty":-9.30069,"marketCap":8257484},{"date":"2026-05-22","current":-1.00338,"twenty":-30.300463,"median":-16.944953,"eighty":-9.258427,"marketCap":11039897},{"date":"2026-05-29","current":-0.734181,"twenty":-30.270525,"median":-16.944953,"eighty":-9.208049,"marketCap":8077973},{"date":"2026-06-05","current":-0.616712,"twenty":-30.203761,"median":-16.9223,"eighty":-9.096306,"marketCap":6785498},{"date":"2026-06-12","current":-0.554714,"twenty":-30.170974,"median":-16.899646,"eighty":-8.688023,"marketCap":6103358},{"date":"2026-06-18","current":-0.497611,"twenty":-30.09328,"median":-16.899646,"eighty":-8.549768,"marketCap":5475071},{"date":"2026-06-26","current":-0.403799,"twenty":-29.717019,"median":-16.899646,"eighty":-8.19902,"marketCap":4442885},{"date":"2026-07-02","current":-0.468244,"twenty":-29.45507,"median":-16.869239,"eighty":-7.814843,"marketCap":5151952},{"date":"2026-07-10","current":-0.50169,"twenty":-29.356886,"median":-16.824134,"eighty":-7.282393,"marketCap":5519948},{"date":"2026-07-17","current":-0.602436,"twenty":-29.345261,"median":-16.824134,"eighty":-6.817991,"marketCap":6628426},{"date":"2026-07-24","current":-0.484151,"twenty":-29.33234,"median":-16.824134,"eighty":-5.045938,"marketCap":5326975},{"date":"2026-07-31","current":-0.416444,"twenty":-29.166606,"median":-16.824134,"eighty":-4.798491,"marketCap":4582006},{"date":"2026-08-07","current":-0.403391,"twenty":-28.898172,"median":-16.793066,"eighty":-4.620329,"marketCap":4438397},{"date":"2026-08-14","current":-0.611409,"twenty":-28.841422,"median":-16.77026,"eighty":-4.540183,"marketCap":6727157},{"date":"2026-08-21","current":-0.603857,"twenty":-28.684328,"median":-16.763724,"eighty":-4.155129,"marketCap":7562255},{"date":"2026-08-25","current":-0.50089,"twenty":-28.645055,"median":-16.763724,"eighty":-3.979343,"marketCap":6272776}],"updateTime":1787735958212},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LIMN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648564017","title":"Liminatus Pharma Amends Innocsai Merger Terms, Targets July 2 Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2648564017","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648564017?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:30","pubTimestamp":1782851459,"startTime":"0","endTime":"0","summary":"Liminatus Pharma amends InnocsAI merger terms, targets July 2 closeLiminatus amended and restated its merger agreement with InnocsAI, restructuring terms to allow closing before stockholder approval.C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL5FhwPw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","LU2210149790.SGD","LU2095319765.USD","SG9999014005.SGD","LIMN","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","BK4112","SG9999014013.SGD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","SG9999014021.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648564451","title":"Liminatus Pharma - Innocsai Equity Holders to Receive up to 19.99% of Liminatus Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2648564451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648564451?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:30","pubTimestamp":1782851400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA6TSB7G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648564450","title":"Liminatus Pharma Amends Definitive Merger Agreement with Innocsai to Expand Oncology Cell Therapy Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2648564450","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648564450?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:30","pubTimestamp":1782851400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA6TSB7G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648564434","title":"Liminatus Pharma - Innocsai Merger Valued at $320 Mln with $0.2 Per Share Issue Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2648564434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648564434?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:30","pubTimestamp":1782851400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA6TSB7G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647733534","title":"Liminatus Pharma Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2647733534","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647733534?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:05","pubTimestamp":1782813904,"startTime":"0","endTime":"0","summary":"Liminatus Pharma announces annual shareholder meetingLiminatus Pharma will hold its annual shareholder meeting in Fullerton, California in July 2026.Shareholders will vote to elect two directors: Nich","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL4vW2PX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904687","title":"Liminatus Pharma issues new warrants for 20,688,000 shares in inducement deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904687","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904687?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:34","pubTimestamp":1780490044,"startTime":"0","endTime":"0","summary":"Liminatus Pharma entered a warrant exercise agreement covering 10,344,000 shares, cutting the exercise price to USD 0.18.Cash exercise expected to generate USD 1.9 million in gross proceeds before fees and expenses.Issuing new unregistered warrants for 20,688,000 shares at USD 0.18, exercisable only after required Nasdaq stockholder approval.New warrants set to expire five years after stockholder approval.Company plans to file an SEC registration statement for resale of shares issuable upon exercise of the new warrants.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDLbYVKZp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4585","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4139","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","LIMN","BK4588","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904560","title":"Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904560","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904560?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:31","pubTimestamp":1780489885,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638361056","title":"Liminatus Pharma appeals Nasdaq delisting notice after missing $50 million market value rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2638361056","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638361056?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:35","pubTimestamp":1779914114,"startTime":"0","endTime":"0","summary":"Liminatus Pharma faces Nasdaq delisting risk for failing to meet $50 million MVLS and $15 million MVPHS continued-listing thresholds.Nasdaq issued a noncompliance notice on May 20, 2026; trading suspension was set for May 29, 2026 absent an appeal by May 27.An appeal request filed May 26, 2026 triggers a stay, pausing any suspension or delisting pending a Nasdaq Hearings Panel decision.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL3vxd3d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637707318","title":"Liminatus Pharma receives Nasdaq delisting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2637707318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637707318?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:50","pubTimestamp":1779443447,"startTime":"0","endTime":"0","summary":"Liminatus Pharma (LIMN) announced that the company received a delisting notice from The Nasdaq Stock Market. On May 20, the company received a noti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-receives-nasdaq-delisting-notice-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-receives-nasdaq-delisting-notice-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365533","title":"Liminatus Pharma appeals Nasdaq delisting notice, trading suspension set May 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365533","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365533?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:28","pubTimestamp":1779409718,"startTime":"0","endTime":"0","summary":"Liminatus Pharma received a Nasdaq delisting notice on May 20, 2026, tied to failures to meet minimum market value thresholds for listed securities and publicly held shares.Trading in the common stock and warrants is set to be suspended at the open on May 29, 2026, unless an appeal is requested by May 27, 2026.An appeal request would pause the suspension and delisting process while the matter is reviewed by a Nasdaq hearings panel.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL1BPKNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","BK4139","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","LIMN","IE00BN0W2W23.USD","SG9999014013.SGD","BK4585","SG9999014021.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365538","title":"Liminatus Pharma Announces Nasdaq Delisting Notification","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365538","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365538?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:28","pubTimestamp":1779409706,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUA9PFH7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637067357","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2637067357","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637067357?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:43","pubTimestamp":1779399780,"startTime":"0","endTime":"0","summary":"American Airlines Group      AAL   108,585,692     13.59     0.64      4.94. Direxion TSLA Bull 2X       TSLL    74,381,609     14.72     0.05      0.34. ProShares UltraPro QQQ      TQQQ    73,481,306     76.95     0.44      0.58. GrShr 2x Sh NVDA Daily       NVD    69,568,217      4.53     0.14      3.19. ProSh UltraPro Shrt QQQ     SQQQ    59,610,117     41.96    -0.23     -0.55. Direxion PLTR Bear 1X       PLTD    41,120,749      7.83    -0.01     -0.14. Defiance Tgt 2x Shrt IONQ   IONZ    40,170,425      2.88    -0.96    -25.00. Leverage 2X Lg TSLA Dly     TSLG    38,851,439      7.24     0.01      0.14. Defiance Tgt 2x Shrt RGTI   RGTZ    37,738,323      4.79    -7.46    -60.90","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLD","07388","LU1127390331.HKD","SG9999014559.SGD","LU1069344957.HKD","LU2552382058.USD","LU0081259029.USD","LU0345769631.USD","LU0823421416.USD","HK0000320223.HKD","LU2487616109.SGD","LU2168563687.JPY","SG9999015978.USD","LU1720051017.SGD","LU0215105999.USD","LU2764263039.SGD","IE0001KFT4U8.USD","LU0345768153.USD","LU1645745479.HKD","LU0444973449.USD","IE00B7KXQ091.USD","LU1629891620.HKD","LU2592432038.USD","BK4581","LU1145028129.USD","IE000YTNTUN2.SGD","LU2168564149.EUR","SG9999014575.USD","LU1861558580.USD","LU0289961442.SGD","IE00BN29S564.USD","HK0000304805.HKD","SGXZ23171101.USD","LU0957791311.USD","LU2089985449.USD","LU0061474705.USD","TSLL","NVDW","IE00BK4W5L77.USD","LU0472753341.HKD","BK4503","07788","IE00BQXX3C00.GBP","AAL","LU0787776722.HKD","HK0000532082.HKD","LU1691799644.USD","LU2271345857.HKD","LU2290526834.HKD","BK4500","BK4515","BK4598","LU2417539215.USD","LU0203347892.USD","BK4527","LU0175139822.USD","LU2100268510.USD","LU2360107168.USD","LU1548497426.USD","TSLA","LU0265550946.USD","BK4549","LU1935042991.SGD","BK4534","LU2360032135.SGD","LU2458330169.SGD","LU1261432733.SGD","TSLW","LU1803068979.SGD","PLTD","LU2168564065.EUR","TSLZ","LU0256863811.USD","LU0868494617.USD","NVD2.UK","LU0792757196.USD","LU2023250504.SGD","SG9999015341.SGD","LU1035775433.USD","NVII","LU2750360641.GBP","LU2954938101.SGD","BK4588","NVDD","SG9999014898.SGD","SG9999004303.SGD","NVDA","IE00B7SZLL34.SGD","NVDS","IE00BWXC8680.SGD","IE00BYXW3230.USD","LU1119994496.HKD","LU1923622614.USD","LU2125909916.SGD","LU1712237335.SGD","LU1861559042.SGD","LU2028103732.USD","BK4605","LU2242649171.HKD","BK4551","LU1839511570.USD","TSDD","LU2357125470.USD","LU0107464264.USD","IE0005OL40V9.USD","IE00B19Z8W00.USD","BK4550","LU0061474960.USD","SG9999018857.SGD","NVDY","LU2250418816.HKD","NVYY","HK0000914686.HKD","TSL","IE0004091025.USD","LU2326559502.SGD","LU2361044865.SGD","SG9999015986.USD","LU0859254822.USD","09366","LU2602419157.SGD","LU1821325948.USD","NVDS.UK","LU2286300806.USD","LU1551013425.SGD","LU1951198990.SGD","LU0823434583.USD","BK4543","LU1914381329.SGD","BK4612","LU2125154778.USD","LU2360106780.USD","LU2999663052.SGD","LU0266013472.USD","LU0788109477.HKD","LU2471134952.CNY","LU2750360997.AUD","SG9999002232.USD","LU2764262908.HKD","IE000ITXATA3.USD","LU0985320562.USD","LU0823414478.USD","3NVD.UK","LU3102509885.SGD","LU1814569148.SGD","LU0072462426.USD","LU1699723380.USD","MUD","LU2236285917.USD","SG9999017495.SGD","LU2047632596.USD","IE00B1XK9C88.USD","INTW","LU0345769128.USD","TSII","IE00BFSS7M15.SGD","LU1974910355.USD","MULL","LU1778281490.HKD","MUU","LU0672654240.SGD","LU2087621335.USD","LU0170899867.USD","LU0097036916.USD","LU0187121727.USD","LU2491050154.USD","LU0070217475.USD","RGTZ","LU0979878070.USD","LU0724617625.USD","LU0345770993.USD","IE00BD6J9T35.USD","LU1084165304.USD","BK4602","LU2063271972.USD","BK4512","IE000W1ABFV2.USD","LU2294711713.HKD","LU1934455863.HKD","LU2361044949.HKD","LU0708995401.HKD","LU1153585028.USD","LU0943347566.SGD","LU1037948541.HKD","LU0174119429.USD","BK4604","BK4555","IE00BJJMRY28.SGD","BK4567","LU2213496289.HKD","LU1267930730.SGD","LU1868836757.USD","LU2168564495.EUR","LU2242650005.HKD","IE000M9KFDE8.USD","IREN","LU0267386448.USD","LU1791710400.SGD","LU2491050071.SGD","TLA","LU1923623000.USD","LU0820561818.USD","LU2083900584.USD","LU1244550577.SGD","LU0211328371.USD","LU1400636574.HKD","LU0823414551.USD","LU2077746001.SGD","LU1983260115.SGD","LU0889566641.SGD","LU0198837287.USD","LU2458330243.SGD","LU1267930813.SGD","LU2462591277.SGD","LU2430703095.HKD","LU2106854487.HKD","LU0124676726.USD","LU0203345920.USD","LU0210528500.USD","LU1400636657.SGD","BK4585","LU0109391861.USD","IE00B1BXHZ80.USD","IE00B3S45H60.SGD","SNVD.UK","LU1935042488.USD","LU0011850046.USD","LU0289960550.SGD","LU0127658192.USD","NVDB","IE00BZ199S13.USD","LU1551013342.USD","NVDU","IE00BJJMRX11.SGD","BK4548","LU0203202063.USD","IE00B19Z9505.USD","LU2237438978.USD","LU0882574139.USD","LU2860962120.EUR","CRSH","LU1064131342.USD","LU2462591350.SGD","LU1429558221.USD","LU0353189680.USD","LU1934455194.USD","LU1496350171.SGD","SGXZ51526630.SGD","IE00B5949003.HKD","LU2168564222.USD","LU0354030511.USD","LU1861127337.USD","LU0823434740.USD","LU0689472784.USD","LU1923622291.USD","LU1868836914.USD","LU2413666426.HKD","LU0158827781.USD","LU1242518857.USD","LU2097344357.USD","AAPL","LU1116320901.HKD","NVDQ","PLTR","NVDX","LU2637965513.SGD","LU2552382132.HKD","LU0077335932.USD","IE00BMPRXN33.USD","NVDG","LU2322448957.HKD","IE00BDRTCR15.USD","LU1935043536.SGD","LU2065171311.SGD","LU1400636491.USD","LU1868836591.USD","BK4587","INTC","BK4554","LU1267930573.SGD","LU0965508806.USD","HK0000304797.USD","LU0321505868.SGD","IE00BQXX3F31.USD","LU0109392836.USD","SG9999001424.SGD","SG9999014906.USD","TSYY","IE00BKDWB100.SGD","LU2247934214.USD","LU0683600562.USD","IE00BKPKM429.USD","LINT","LU1868837136.USD","LU2746668974.SGD","LU0476273544.USD","LU2249611893.SGD","LU0210536198.USD","SG9999014567.USD","LU0323591593.USD","TSLR","LU0820562030.AUD","SGXZ31699556.SGD","LU1066053197.SGD","LU0069063385.USD","BK4008","LU1721428933.USD","BK4535","LU1989772923.USD","LU2087625088.SGD","LU2322448791.USD","LU0143551892.USD","LU2265009873.SGD","LU0154236417.USD","IE00BK4W5M84.HKD","LU0310799852.SGD","SG9999014880.SGD","SGXZ81514606.USD","TESL","LU1116320737.USD","LU1066051225.USD","IE0004445015.USD","LU1791710582.SGD","SG9999015945.SGD","IE00BSNM7G36.USD","LU2023250330.USD","KEEL","LU2111349929.HKD","LU2746668461.USD","LU1868837300.USD","HK0000306685.HKD","LU0251132253.USD","LU1720051108.HKD","LU2125909247.SGD","TSLG","LU2430703178.SGD","LU0079474960.USD","LU2756315318.SGD","LU1280957306.USD","LU0965509010.AUD","LU1267930490.SGD","IE00BQXX3D17.EUR","SG9999014542.SGD","SQQQ","LU2896262040.SGD","IONQ","LU2357305700.SGD","LU2462157665.USD","TEST","NVD3.UK","SG9999014914.USD","LU0048584097.USD","LU1989772840.SGD","LU2237957811.SGD","LU2125909593.SGD","LU2505996681.GBP","LU0965509101.SGD","LU2463028550.USD","04335","HK0000819398.USD","LU1670756490.USD","LU0096362180.USD","LU2237957902.USD","IE00BJTD4V19.USD","LU1642822529.SGD","LU2413666699.HKD","LU0342679015.USD","TSLT","GB00BDT5M118.USD","LU0210533765.USD","LU2552382215.SGD","LU2065171402.SGD","BK4608","LU1861215975.USD","LU2433249047.HKD","LU2403377893.USD","LU2764263203.CNY","AALG","LU1815333072.USD","LU2471134879.HKD","TSLY","LU1852331112.SGD","LU0080751232.USD","LU0256863902.USD","IE00B3SWFQ91.USD","BK4575","SGXZ99366536.SGD","LU1066051811.HKD","IE0004445239.USD","LU2491049909.HKD","LU1988902786.USD","LU0225283273.USD","IE0034235303.USD","LU2065169927.USD","IE0034235188.USD","LU0211327993.USD","LU1242518931.SGD","MU","LU2756315664.SGD","LU1366333091.USD","LU1674673428.USD","BK4547","ANV","LU0316494557.USD","IE00BJTD4N35.SGD","IE00B775SV38.USD","LU0310800379.SGD","LU0133085943.USD","TSLS","LU2092937148.SGD","IONZ","LU0861579265.USD","LU0354030438.USD","NVD","LU1674673691.USD","LU2505996509.AUD","LU2125909759.SGD","BK4574","LU0823411888.USD","SG9999015952.SGD","LU0234572021.USD","IE00B19Z8X17.USD","LU0029864427.USD","LU2244417387.USD","LU0157215616.USD","TSLI","WMT","HK0000320264.USD","IE00B19Z3B42.SGD","LU2720916845.USD","LU0128525929.USD","LU0353189763.USD","BK4529","SG9999000418.SGD","LU2430703251.USD","BK4592","IE00BJLML261.HKD","IE0003U64NQ7.SGD","LU2394011477.USD","LU1366192091.USD","LU1202635105.USD","IE0009G5SDU7.USD","LU0265550359.USD","LU0786609619.USD","LU0528227936.USD","LU0320765059.SGD","IE00BMPRXR70.SGD","LU0203201768.USD","BK4533","LU0466842654.USD","SOFI","TSLO","DIPS","LU0719512351.SGD","LU2092627202.USD","07366","LU1992135472.HKD","IE00BDCRKT87.USD","BK4553","NVIW.SI","TSLQ","BK4516","LU2420271590.USD","LU0942090050.USD","LU2272731865.HKD","IE00B19Z3581.USD","LU0444971666.USD","LU2089284900.SGD","IE00BZ1G4Q59.USD","LU1496350502.SGD","NVDO","LU0321505439.SGD","IE0004086264.USD","LU2148611432.USD","LU0106261372.USD","LU2272731600.USD","IE00BHPRN162.USD","LU0061475181.USD","LU2456880835.USD","LU0820561909.HKD","LU2065170008.USD","BK4566","BK4579","HK0000914660.USD","LU0006306889.USD","IE0009356076.USD","LU0689626769.HKD","LU0557290698.USD","LU2452424414.USD","LU2506951792.HKD","LIMN","LU1917777945.USD","LU0345768740.USD","IE00BFSS8Q28.SGD","LU0094547139.USD","2NVD.UK","HK0000306701.USD","IE00B3M56506.USD","LU2125154935.USD","LU0053666078.USD","LU0234570918.USD","LU1804176565.USD","IE00B4JS1V06.HKD","LU2054465674.USD","LU0347712357.USD","TQQQ","IE0034235295.USD","09766","BK4532","LU2048586759.USD","LU0964807845.USD","LU1935042215.USD","LU0158827948.USD","LU2461242641.AUD","LU2272731782.SGD","LU1623119135.USD","LU0957808578.USD","LU0289739343.SGD","IE00B775H168.HKD","LU0390134368.USD","LU1718418525.SGD","LU2089283258.USD","LU0868494708.USD","07766","LU0274383776.USD","LU0511384066.AUD","LU2357627491.SGD","LU1232071149.USD","IE0002270589.USD","LU2097344431.USD","LU0096364046.USD","LU1861220033.SGD","LU2931357623.SGD","LU2361045086.USD","LU0348723411.USD","LU2473716301.USD","LU0308772762.SGD","LU0889565833.HKD","RGTI","LU0082616367.USD","LU0057025933.USD","IE000KEQY171.SGD","LU0965509283.SGD","LU1633808545.USD","LU2471134796.USD","BK4141","LU1435385759.SGD","LU1989764664.SGD","SG9999002224.SGD","IE00BMPRXQ63.HKD","LU1244550494.USD","LU2191332357.HKD","LU1244550221.USD","LU1037948897.HKD","TSLP","LU1989764748.USD","LU1992135399.USD","LU0642271901.SGD","LU2381873111.SGD","LU1934455277.USD","NVDL","LU0494093205.USD","LU2543165471.USD","LU2211815571.USD","LU1316542783.SGD","SG9999018865.SGD","BK4511","LU2023251221.USD","IE00B4YYXB79.USD","NDX","LU1815336760.USD","LU1935043023.USD","LU1951200564.SGD","BK4614","LU0708994859.HKD","SG9999015358.SGD","LU0345770308.USD","LU1323610961.USD","LU0823421333.USD","BK4099","LU2108987350.USD","LU1571399168.USD","LU0276348264.USD","LU0417517546.SGD","LU0238689110.USD","IE00BKVL7J92.USD","LU0640476718.USD","LU0056508442.USD","LU1066051498.USD","LU2264538146.SGD","LU2471134523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333002","title":"Liminatus Pharma agrees to merge with InnocsAI in $320 million stock deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333002","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333002?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:07","pubTimestamp":1779365276,"startTime":"0","endTime":"0","summary":"Liminatus Pharma entered a definitive merger agreement dated May 17, 2026, to combine with InnocsAI, a biotech focused on CAR-T and antibody-based oncology therapies.InnocsAI is set to merge into a newly formed Liminatus Delaware subsidiary, leaving the subsidiary as a wholly owned unit of Liminatus.InnocsAI members are slated to receive 1,600,000,000 shares of Liminatus common stock priced at $0.2 per share, implying a transaction value of about $320 million.The consideration also includes contingent value rights tied to 20% of future net proceeds from certain strategic transactions involving the acquired assets.The deal is intended to expand Liminatus’ oncology pipeline, led by CAR-T programs including IBC101 for relapsed or refractory B-cell malignancies and INC101 for solid tumors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL6DQTxf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","LIMN","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014039.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","NDAQ","LU2210150020.SGD","LU2210149790.SGD","BK4139","IE00BKPKM429.USD","LU2095319765.USD","SG9999014005.SGD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333790","title":"Liminatus Pharma Inc - Innocsai Members to Receive 20% of Future Net Proceeds From Certain Strategic Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333790?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:04","pubTimestamp":1779365040,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA53TK3Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637272333","title":"Liminatus Pharma Announces Proposed Merger With Innocsai to Expand Oncology Cell Therapy Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2637272333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637272333?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:04","pubTimestamp":1779365040,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA53TK3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637038042","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637038042","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637038042?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:08","pubTimestamp":1779361719,"startTime":"0","endTime":"0","summary":"Wheeler Real Estate Investment Trust  shares were up 80% in Thursday premarket activity following a nearly 2% fall in the previous session.Liminatus Pharma  stock was 50% higher after the company agreed to merge with InnocsAI.Agape ATP  shares were up 43% after a 3.2% loss in the previous session.Co-Diagnostics  stock was 36% higher after the company announced a $3 million private placement, extending Wednesday's 21% rally.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LIMN","BK4082","CODX","WHLR","ATPC","BK4139","BK4231","BK4568","BK4080","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637875492","title":"Liminatus Pharma Inc - Enters Merger Agreement With Innocsai Llc on May 17, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637875492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637875492?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:04","pubTimestamp":1779311052,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nFWN41X0Z9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637754908","title":"Liminatus Pharma Inc - Innocsai Members to Receive 1.6 Bln Shares at $0.20 per Share and 20% Contingent Value Rights - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637754908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637754908?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:04","pubTimestamp":1779311052,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nFWN41X0Z9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637875485","title":"Liminatus Pharma agrees to buy InnocsAI in 1,600,000,000-share deal at $0.2 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2637875485","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637875485?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:01","pubTimestamp":1779310894,"startTime":"0","endTime":"0","summary":"Liminatus Pharma entered a merger agreement on May 17, 2026 to acquire InnocsAI through a merger into a newly formed wholly owned subsidiary.InnocsAI members are set to receive 1,600,000,000 shares of Liminatus common stock priced at USD 0.2 per share.The deal also includes contingent value rights tied to 20% of net proceeds from any future strategic sale, out-licensing, transfer, or exit of the acquired InnocsAI assets.The acquired portfolio centers on oncology biologic and cellular therapy programs, including a CD19xCD22 CAR-T candidate in Phase 1/2a authorization in South Korea for relapsed or refractory diffuse large B-cell lymphoma.Valetudo Therapeutics, an InnocsAI member, is controlled by Liminatus CEO and director Chris Kim.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interprete","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL935F5N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635005859","title":"Liminatus Pharma Q1 FY26 net loss widens to $1.12 million; operating loss widens 317% to $1.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635005859","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635005859?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:53","pubTimestamp":1778878399,"startTime":"0","endTime":"0","summary":"Liminatus Pharma reported a net loss of $1.12 million for the three months ended March 31, 2026, widening 243% year over year.Operating loss widened to $1.1 million, driven by total operating expenses of $1.1 million, up 317%.General and administrative expense climbed to $700,898, up 165%, while research and development expense was $400,000 versus no such costs a year earlier.Cash totaled $1.91 million at March 31, 2026; net cash used in operating activities increased to $2.02 million from $159,393.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL6r4hST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}]}}